USD 2.3 billion
Glioblastoma Multiforme Treatment Market Size, Share, Growth Analysis, By Type(Surgery, Radiation Therapy, Chemotherapy, and Targeted Therapy.), By Application(Newly Diagnosed glioblastoma multiforme treatment, Recurrent glioblastoma multiforme treatment, Palliative Care, Clinical Trials and Pediatric glioblastoma multiforme treatment.), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2105 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
65
|Figures:
75
Glioblastoma Multiforme Treatment Market Insights
Glioblastoma Multiforme Treatment Market size was valued at USD 2.50 billion in 2022 and is poised to grow from USD 2.72 billion in 2023 to USD 5.39 billion by 2031, growing at a CAGR of 8.90% in the forecast period (2024-2031).
The global market for glioblastoma multiforme treatment has witnessed substantial growth in recent years, driven by the increasing incidence of glioblastoma multiforme treatment cases worldwide and the growing demand for effective treatment options. The increasing incidence of glioblastoma multiforme treatment, coupled with the limited treatment options available, has created a pressing need for innovative and effective therapies, thereby fueling market growth. Advancements in medical research and technology have contributed to the development of novel treatment modalities for glioblastoma multiforme treatment. The market has witnessed a shift towards personalised medicine approaches, with a focus on targeted therapies and immunotherapies. Targeted therapies, such as tyrosine kinase inhibitors and monoclonal antibodies, aim to disrupt specific molecular pathways involved in glioblastoma multiforme treatment progression. Immunotherapies, including immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cell therapy, harness the body's immune system to recognize and destroy cancer cells. These advancements have significantly improved treatment outcomes and have spurred the growth of the glioblastoma multiforme treatment market.
US Glioblastoma Multiforme Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Surgery
Fastest Growth
Surgery
Growth Rate
8.9% CAGR
Global Glioblastoma Multiforme Treatment By Country ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Glioblastoma Multiforme Treatment Market Segmental Analysis
The global glioblastoma multiforme treatment market is segmented by type, application, and region. Based on type, the market can be segmented into Surgery, Radiation Therapy, Chemotherapy and Targeted Therapy. Based on application, the market is segmented into Newly Diagnosed glioblastoma multiforme treatment, Recurrent glioblastoma multiforme treatment, Palliative Care, Clinical Trials and Paediatric glioblastoma multiforme treatment. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Glioblastoma Multiforme Treatment Market Analysis by Type
In the global Glioblastoma Multiforme (glioblastoma multiforme treatment) Treatment market, among the treatment types such as Surgery, Radiation Therapy, Chemotherapy, and Targeted Therapy, the dominant type of treatment is Surgery. Surgery plays a crucial role in the management of glioblastoma multiforme treatment by removing as much of the tumour as possible, thereby reducing the tumour burden and relieving symptoms.
While Surgery remains the dominant treatment approach for glioblastoma multiforme treatment, the fastest-growing type of treatment in the market is Targeted Therapy. Targeted Therapy involves the use of specific drugs or agents that selectively target cancer cells while sparing healthy cells. This treatment approach is gaining prominence due to its potential for personalised and more effective treatments. Targeted Therapy offers the advantage of precise molecular targeting, allowing for tailored treatment strategies based on the specific genetic mutations or biomarkers found in the tumour. As research advances and more targeted therapies become available, their adoption is expected to grow rapidly in the glioblastoma multiforme treatment market.
Glioblastoma Multiforme Treatment Market Analysis by Application
Newly diagnosed glioblastoma multiforme treatment holds the dominant position in the global glioblastoma multiforme treatment market. This is primarily due to the high incidence rate of glioblastoma multiforme treatment and the urgent need for effective treatment options at the early stages of the disease. Newly diagnosed glioblastoma multiforme treatment refers to cases where patients are diagnosed with glioblastoma multiforme treatment for the first time. As glioblastoma multiforme treatment is an aggressive and fast-growing brain tumour, early intervention and treatment are crucial for improving patient outcomes. Consequently, there is a strong focus on research and development of novel therapies specifically designed for newly diagnosed glioblastoma multiforme treatment patients, leading to a dominant position within the glioblastoma multiforme treatment market.
Clinical trials represent the fastest-growing segment in the global glioblastoma multiforme treatment market. Clinical trials are research studies conducted to evaluate new treatment approaches, therapies, or interventions. In the context of glioblastoma multiforme treatment, clinical trials play a vital role in advancing the understanding of the disease and exploring innovative treatment options. The complexity and challenges associated with glioblastoma multiforme treatment necessitate ongoing research efforts to develop more effective therapies. Clinical trials provide an avenue for testing novel drugs, immunotherapies, targeted therapies, and combination treatments that have the potential to improve patient outcomes. The continuous growth and expansion of clinical trials contribute to their status as the fastest-growing segment within the glioblastoma multiforme treatment market.
Global Glioblastoma Multiforme Treatment By Type
To get detailed analysis on other segments, Request For Free Sample Report
Glioblastoma Multiforme Treatment Market Regional Insights
The most dominant region in the global glioblastoma multiforme treatment market is North America. This region has a strong presence of key pharmaceutical companies, advanced healthcare infrastructure, and a significant focus on research and development. North America, particularly the US, has witnessed substantial investments in glioblastoma multiforme treatment research and clinical trials. Moreover, the region has a higher prevalence of glioblastoma multiforme treatment cases, driving the demand for effective treatment options. These factors contribute to the dominance of North America in the global glioblastoma multiforme treatment market.
As for the fastest-growing region in the global glioblastoma multiforme treatment market, Asia-Pacific is gaining prominence. This region has a large population base and is witnessing an increasing incidence of glioblastoma multiforme treatment cases. Furthermore, countries like China, India, and Japan are investing in healthcare infrastructure development and research activities. The growing awareness about glioblastoma multiforme treatment and the availability of advanced treatment options are propelling the market growth in this region. Additionally, emerging economies in Asia-Pacific are focusing on improving access to healthcare, which is expected to drive the demand for glioblastoma multiforme treatment treatments.
Global Glioblastoma Multiforme Treatment By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Glioblastoma Multiforme Treatment Market Dynamics
Glioblastoma Multiforme Treatment Market Drivers
Increasing Incidence of Glioblastoma Multiforme
- The increasing occurrence of glioblastoma multiforme, an aggressive brain cancer, is a significant driver of the market. As the prevalence of glioblastoma multiforme treatment continues to rise worldwide, there is a growing need for the development of effective treatment options. This drives the demand for glioblastoma multiforme treatment treatments and fuels market growth.
Glioblastoma Multiforme Treatment Market Restraints
High Treatment Costs
- The cost of glioblastoma multiforme treatment poses a financial burden for patients, primarily due to the expenses associated with surgery, radiation therapy, chemotherapy, and supportive care. The high treatment costs can impede patient access to advanced therapies and impact the affordability of treatments. Furthermore, reimbursement policies play a crucial role in determining patient access to these treatments, thereby influencing market growth.
Request Free Customization of this report to help us to meet your business objectives.
Glioblastoma Multiforme Treatment Market Competitive Landscape
The global competitive landscape of the glioblastoma multiforme treatment market is characterised by intense research and development activities, collaborations, and strategic initiatives. glioblastoma multiforme treatment is a highly aggressive and difficult-to-treat brain tumour, and the market for its treatment is witnessing significant advancements and competition. In this competitive landscape, pharmaceutical companies, research institutions, and academic centres are at the forefront of developing innovative treatment approaches for glioblastoma multiforme treatment. These entities focus on improving patient outcomes by exploring novel therapeutic strategies and optimising existing treatment modalities.
Glioblastoma Multiforme Treatment Market Top Player’s Company Profiles
- Merck & Co., Inc. (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Bristol Myers Squibb Company (US)
- Eli Lilly and Company (US)
- AbbVie Inc. (US)
- Pfizer Inc. (US)
- Tocagen Inc. (US)
- Kazia Therapeutics Limited (Australia)
- DelMar Pharmaceuticals, Inc. (US)
- Arbor Pharmaceuticals, LLC (US)
- BTG International Ltd (United Kingdom)
- Mundipharma International Limited (United Kingdom)
- Northwest Biotherapeutics (US)
- Orbus Therapeutics Inc. (US)
- VBL Therapeutics (Israel)
- GT Medical Technologies, Inc. (US)
- Oncolys Biopharma Inc. (Japan)
- Tocagen (US)
- ValiRx Plc (United Kingdom)
Glioblastoma Multiforme Treatment Market Recent Developments
- In March 2023, Merck & Co., Inc. announced that the FDA approved Keytruda (pembrolizumab) in combination with temozolomide for the adjuvant treatment of adults with newly diagnosed, high-risk glioblastoma multiforme treatment.
- In February 2023, Bristol-Myers Squibb Company announced that the FDA granted accelerated approval to Opdivo (nivolumab) in combination with ipilimumab for the treatment of adults with recurrent glioblastoma multiforme treatment who have received prior therapy.
- In January 2023, Janssen Pharmaceutical Companies announced that the FDA granted breakthrough therapy designation to tofacitinib for the treatment of adults with relapsed or refractory glioblastoma multiforme treatment.
- In December 2022, Denali Therapeutics, Inc. announced that the FDA granted fast track designation to DNL3101 for the treatment of glioblastoma multiforme treatment.
- In November 2022, Atara Biotherapeutics, Inc. announced that the FDA granted orphan drug designation to ATA188 for the treatment of glioblastoma multiforme treatment.
Glioblastoma Multiforme Treatment Key Market Trends
- Increasing Use of Targeted Therapies: Targeted therapies are designed to target specific molecules involved in the growth and spread of glioblastoma multiforme treatment cells. These therapies have shown promise in improving the survival rates of patients with glioblastoma multiforme treatment.
- Development of New Immunotherapies: Immunotherapies are designed to boost the body's immune system to fight cancer cells. These therapies are still in the early stages of development, but they have shown promise in treating glioblastoma multiforme treatment.
- The Increasing Demand for Personalised treatment: Personalised treatment is tailored to the individual patient's tumour profile. This approach has the potential to improve the efficacy and safety of treatment for glioblastoma multiforme treatment patients.
Glioblastoma Multiforme Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to the global glioblastoma multiforme treatment analysis, it examines the various treatment modalities available for glioblastoma multiforme treatment, including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. It evaluates the efficacy and limitations of these treatment options, emphasising the need for innovative therapies that can improve patient outcomes and overall survival rates. Key market trends and developments are discussed, such as the increasing focus on personalised medicine approaches for glioblastoma multiforme treatment. This trend signifies a shift towards precision medicine, offering potential opportunities for novel treatment approaches in the glioblastoma multiforme treatment market. The competitive landscape of the global glioblastoma multiforme treatment market is thoroughly analysed, encompassing both established pharmaceutical companies and emerging players.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.50 billion |
| Market size value in 2031 | USD 5.39 billion |
| Growth Rate | 8.90% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Glioblastoma Multiforme Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Glioblastoma Multiforme Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Glioblastoma Multiforme Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Glioblastoma Multiforme Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Glioblastoma Multiforme Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Glioblastoma Multiforme Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
